spacer
home > pmps > winter 2001 > the quest for an unbroken cool chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Quest for an Unbroken Cool Chain

According to The World Health Organization (WHO), a quarter of all vaccines transported by air cargo will not give the intended protection because of broken or inefficient cool chains. The UK Medicines Control Agency backs up the WHO's findings, and states that 25 per cent of all serious deficiencies recorded by official medicine inspectors auditing pharmaceutical wholesale distributors in the UK were related to the control and monitoring of storage and transit temperatures.

These are startling and worrying statistics that can cost lives. Leading pharmaceutical companies invest hundreds of millions of dollars in order to research, develop and patent new products. It's a process that takes an average of eight to ten years from start to finish. Until recently, however, the transportation of their products by air cargo was far less sophisticated. Broken cool chains represent a significant cost to the pharmaceutical industry in terms of product integrity and performance. They can result in reduced product effectiveness, shorter shelf life, and even become potentially life threatening. However, there is no excuse for poor performance. Proven temperature control solutions are now readily available, the result of extensive research, development, investment and consultation with the pharmaceutical industry.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Lars Skarke, CEO of Envirotainer
Lars Skarke has founded and developed various companies over the last 30 years. In 1993 he entered the air cargo business, becoming part owner of Frigotainer, a company manufacturing insulated air cargo containers. As CEO, Lars has guided the company - now under the name Envirotainer - in its development as a provider of air cargo temperature management, with state-of-the-art temperature-controlled containers, a global logistic solution and temperature management know-how. .

spacer
Lars Skarke
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement